Skip to main content
Log in

The Quality of Life Committee of the Clinical Trials Group of the National Cancer Institute of Canada: organization and functions

  • Special Report
  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

The Quality of Life Committee of the National Cancer Institute of Canada Clinical Trials Group has successfully advocated the adoption of quality of life outcomes in Canadian clinical trials in patients with cancer. It has developed a policy promoting quality of life assessment in phase III trials and developed writing guidelines to assist clinical investigators when developing protocols for proposed studies. As a result, all phase III clinical trials instituted since the policy was developed have quality of life assessment as a part of their objectives. It has assisted the Clinical Trials Group office personnel in the development of procedures for the conduct of quality of life assessments in clinical trials with the result that the completion rate of self-report questionnaires is very high. The Committee maintains contact with other clinical trials groups and organizations having an interest in measuring quality of life in cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Osoba D. Measuring the effect of cancer on quality of life. In: Osoba D, ed.Effect of Cancer on Quality of Life. Boca Raton: CRC Press, 1991: 26–40.

    Google Scholar 

  2. Levine MN. Incorporation of quality of life assessment into clinical trials. In: Osoba D, ed.Effect of Cancer on Quality of Life. Boca Raton: CRC Press, 1991: 106–111.

    Google Scholar 

  3. Osoba D, Aaronson NK, Till JE. A practical guide for selecting quality of life measures in clinical trials and practice. In: Osoba D, ed.Effect of Cancer on Quality of Life. Boca Raton: CRC Press, 1991: 90–104.

    Google Scholar 

  4. Aaronson NK, Ahmedzai S, Bullinger M, et al. The EORTC core quality-of-life questionnaire: interim results of an international field study. In: Osoba D, ed.Effect of Cancer on Quality of Life. Boca Raton: CRC Press, 1991: 185–203.

    Google Scholar 

  5. Levine MN, Guyatt GH, Gent M et al. Quality of life stage II breast cancer: an instrument for clinicial trials.J Clin Oncol 1988;6: 1798–1810.

    Google Scholar 

  6. Sadura A, Pater J, Levine M,et al. Quality of life assessment: patient compliance with questionnaire completion. Society for Clinical Trials, International Society for Clinical Biostatistics Joint Meeting. Brussels, Belgium. 1991 (Abstract).

  7. Schipper H, Clinch J, McMurray A, et al. Measuring quality of life in cancer patients: The Functional Living Index-Cancer: development and validation.J Clin Oncol 1984;2: 472–483.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Osoba, D. The Quality of Life Committee of the Clinical Trials Group of the National Cancer Institute of Canada: organization and functions. Qual Life Res 1, 211–218 (1992). https://doi.org/10.1007/BF00635620

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00635620

Key words

Navigation